R&D
R&D CENTER
Medinno's R&D Center

is developing stem cell therapeutics to overcome neurodegenerative diseases with comprehensive research of stem cells and technological innovation.

image
  • 01

    Investigation of therapeutic effects MOA of Medinno's stem cell therapies

  • 02

    Development of novel stem cells therapeutics

  • 03

    Establishment of highly efficient productions & processes of stem cells

Highly Efficient
Stem Cell Therapy

Mesenchymal
Stem Cell Therapy

Medinno Inc.
R&D Center

Neural Stem
Cell Therapy

Next Generation
Pipelines

Accreditation Letter
image
Facility
image image image image image image image
Related Materials
Years Category Title Link File
2021 Paper Adult human multipotent neural cells could be distinguished from other cell-types by pro-angiogenic paracrine effects via MCP-1 and GRO
링크
링크
2021 Paper Optimal Preclinical Conditions for Using Adult Human Multipotent Neural Cells in the Treatment of Spinal Cord Injury
링크
링크
2019 Paper Dysregulation of the SNARE-binding protein Munc18-1 impairs BDNF secretion and synaptic neurotransmission: a novel interventional target to protect the aging brain
링크
링크
2018 Paper Optimized Clump Culture Methods for Adult Human Multipotent Neural Cells
링크
링크
2018 Paper In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury
링크
링크
2018 Paper Significant therapeutic effects of adult human multipotent neural cells on spinal cord injury
링크
링크
2018 Paper In Vivo Spinal Distribution of Cy5.5 Fluorescent Dye after Injection via the Lateral Ventricle and Cisterna Magna in Rat Model
링크
링크
2017 Paper The Significance of SDF-1α-CXCR4 Axis in In Vivo Angiogenic Ability of Human Periodontal Ligament Stem Cells
링크
링크
맨위로